GlobeNews Wire

EmblemHealth and Prime Therapeutics Pioneer New Pharmacy Benefit Collaboration

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- EmblemHealth, one of the largest not-for-profit health insurers in the nation, today…

5 months ago

Tevogen Senior Management Engages with Business and Community Leaders and Highlights Recent Progress

WARREN, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), in ongoing community,…

5 months ago

Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa

OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Melissa Appeal to help those…

5 months ago

Anteris DurAVR THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year

MINNEAPOLIS and BRISBANE, Australia, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR,…

5 months ago

SonderCare Launches Impulse Essential 39 Residential Comfort Bed, Expanding Affordable Luxury Homecare Options in the United States

Introducing a new standard in entry-level homecare beds — SonderCare’s Impulse Essential delivers premium comfort, safety, and design at an…

5 months ago

Varonis Announces $150 Million Share Repurchase Authorization

October 28, 2025 16:05 ET  | Source: Varonis Systems, Inc. MIAMI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc.…

5 months ago

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

October 28, 2025 16:05 ET  | Source: Tactile Systems Technology, Inc. MINNEAPOLIS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tactile Systems…

5 months ago

Varonis Announces Third Quarter 2025 Financial Results

Annual recurring revenues increased 18% year-over-yearSaaS ARR as a percentage of total ARR was approximately 76%Year-to-date cash from operations generated…

5 months ago

Anteris Technologies Announces First Patients Treated in DurAVR THV Global Pivotal Trial (the PARADIGM Trial)

MINNEAPOLIS, United States and BRISBANE, Australia, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company)…

5 months ago

Aurora Spine Launches New Biologics Portfolio

New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics October 27, 2025…

5 months ago